Experienced in Hairy Cell Leukemia (HCL)

Roland Giger

Head And Neck Surgery Inselspital, 
Bern, BE, CH 
Experienced in Hairy Cell Leukemia (HCL)
Head And Neck Surgery Inselspital, 
Bern, BE, CH 
OverviewLocationsClinical Research

Overview

Roland Giger practices in Bern, Switzerland. Mr. Giger is rated as an Experienced expert by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Laryngectomy, and Gastrostomy.

His clinical research consists of co-authoring 102 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hairy Cell Leukemia (HCL).

Gender
Male

Locations

Head And Neck Surgery Inselspital, Bern, BE, Switzerland
Other Locations
Head And Neck Surgery, Basel, BS, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicenter Randomized Trial Comparing an Individualized De-intensified and Conventional Follow-up Strategy After Curative Treatment in Head and Neck Cancer
Multicenter Randomized Trial Comparing an Individualized De-intensified and Conventional Follow-up Strategy After Curative Treatment in Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: IRX-2, Cyclophosphamide, Indomethacin, Omeprazole
Study Phase: Phase 2
View 1 Less Clinical Trial

102 Total Publications

Patient Experiences Before and After the Implementation of Advanced Nursing Practice for Head and Neck Cancer.
Patient Experiences Before and After the Implementation of Advanced Nursing Practice for Head and Neck Cancer.
Journal: Clinical journal of oncology nursing
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Giger's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile